Lv Z - Search Results

1

TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma.

Xiao H, Tong R, Yang B, Lv Z, Du C, Peng C, Ding C, Cheng S, Zhou L, Xie H, Wu J, Zheng S. Xiao H, et al. Among authors: lv z. Cancer Lett. 2016 Oct 28;381(2):370-9. doi: 10.1016/j.canlet.2016.08.013. Epub 2016 Aug 18. Cancer Lett. 2016. PMID: 27554639

2

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L. Cheng J, et al. Among authors: lv z. Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21763068

3

Coding-noncoding gene expression in intrahepatic cholangiocarcinoma.

Wang J, Xie H, Ling Q, Lu D, Lv Z, Zhuang R, Liu Z, Wei X, Zhou L, Xu X, Zheng S. Wang J, et al. Among authors: lv z. Transl Res. 2016 Feb;168:107-121. doi: 10.1016/j.trsl.2015.07.007. Epub 2015 Aug 4. Transl Res. 2016. PMID: 26297049

4

Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma.

Cheng S, Luo M, Ding C, Peng C, Lv Z, Tong R, Xiao H, Xie H, Zhou L, Wu J, Zheng S. Cheng S, et al. Among authors: lv z. Gene. 2016 Oct 10;591(1):236-244. doi: 10.1016/j.gene.2016.07.020. Epub 2016 Jul 8. Gene. 2016. PMID: 27397650

5

Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.

Cheng S, Jiang X, Ding C, Du C, Owusu-Ansah KG, Weng X, Hu W, Peng C, Lv Z, Tong R, Xiao H, Xie H, Zhou L, Wu J, Zheng S. Cheng S, et al. Among authors: lv z. Int J Mol Sci. 2016 Aug 22;17(8):1373. doi: 10.3390/ijms17081373. Int J Mol Sci. 2016. PMID: 27556459 Free PMC article.

6

KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling.

Tong R, Yang B, Xiao H, Peng C, Hu W, Weng X, Cheng S, Du C, Lv Z, Ding C, Zhou L, Xie H, Wu J, Zheng S. Tong R, et al. Among authors: lv z. Oncotarget. 2017 Jun 6;8(23):37717-37729. doi: 10.18632/oncotarget.17145. Oncotarget. 2017. PMID: 28465479 Free PMC article.

7

Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.

Chen Y, Ling Z, Cai X, Xu Y, Lv Z, Man D, Ge J, Yu C, Zhang D, Zhang Y, Xie H, Zhou L, Wu J, Zheng S. Chen Y, et al. Among authors: lv z. Cancer Res. 2022 Feb 15;82(4):599-614. doi: 10.1158/0008-5472.CAN-21-1628. Cancer Res. 2022. PMID: 34916222

8

Interleukin-35: the future of hyperimmune-related diseases?

Ye S, Wu J, Zhou L, Lv Z, Xie H, Zheng S. Ye S, et al. Among authors: lv z. J Interferon Cytokine Res. 2013 Jun;33(6):285-91. doi: 10.1089/jir.2012.0086. Epub 2013 Mar 8. J Interferon Cytokine Res. 2013. PMID: 23472662 Review.

9

Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy.

Cheng J, Gao F, Chen X, Wu J, Xing C, Lv Z, Xu W, Xie Q, Wu L, Ye S, Xie H, Zheng S, Zhou L. Cheng J, et al. Among authors: lv z. Mol Carcinog. 2014 Oct;53(10):820-32. doi: 10.1002/mc.22040. Epub 2013 May 9. Mol Carcinog. 2014. PMID: 23661548

10

Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells.

Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du C, Peng C, Xie H, Zhou L, Wu J, Zheng S. Ding C, et al. Among authors: lv z. Int J Mol Sci. 2014 Mar 6;15(3):4060-76. doi: 10.3390/ijms15034060. Int J Mol Sci. 2014. PMID: 24663081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,593 results

Search Page

Filters